SK694A3 - Process for the preparation of diphenyl derivatives - Google Patents

Process for the preparation of diphenyl derivatives Download PDF

Info

Publication number
SK694A3
SK694A3 SK6-94A SK694A SK694A3 SK 694 A3 SK694 A3 SK 694A3 SK 694 A SK694 A SK 694A SK 694 A3 SK694 A3 SK 694A3
Authority
SK
Slovakia
Prior art keywords
group
compound
formula
carbon atoms
alkyl group
Prior art date
Application number
SK6-94A
Other languages
Slovak (sk)
Inventor
Adalbert Wagner
Neerja Bhatnagar
Jean Buendia
Christine Griffoul
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SK694A3 publication Critical patent/SK694A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B37/00Reactions without formation or introduction of functional groups containing hetero atoms, involving either the formation of a carbon-to-carbon bond between two carbon atoms not directly linked already or the disconnection of two directly linked carbon atoms
    • C07B37/04Substitution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The invention relates to a method for the preparation of a compound of the general formula (I) <IMAGE> in which X represents an optionally protected formyl group and R denotes a group which is itself inert to the reaction conditions of the synthesis, for example -CN, characterised in that a compound of the general formula (II) <IMAGE> where X is as defined above, is reacted with a substituted phenyl halogen compound of the formula (III) <IMAGE> where Hal denotes e.g. bromine. The compounds are useful intermediates for pharmaceutical synthesis.

Description

Spôsob výroby derivátov difenyluProcess for preparing diphenyl derivatives

Oblasť technikyTechnical field

Vynález sa týka špeciálnych derivátov difenylu a spôsobu ich výroby.The invention relates to special diphenyl derivatives and to a process for their preparation.

Doterajší stav technikyBACKGROUND OF THE INVENTION

Pri výrobe účinných látok, ako sú napríklad liečivá ochorenia krvného obehu, sa ukázalo, že pri výrobnom postupe sú deriváty difenylu dôležitým medzi produktom. Napríklad v EP-A 503 162 je opísaná príprava liečiv znižujúcich krvný tlak, ktoré ako účinnú zložku obsahujú zlúčeniny typu antagonistov receptorov angiotenzínu II, pre ktoré je charakteristický systém špeciálne substituovaného difenylu.In the manufacture of active substances, such as blood circulation drugs, it has been shown that diphenyl derivatives are important among the product in the manufacturing process. For example, EP-A 503 162 discloses the preparation of blood pressure lowering medicaments comprising as active ingredient compounds of the angiotensin II receptor antagonist type characterized by a specially substituted diphenyl system.

Až doposiaľ boli popísané rôzne spôsoby výroby substituovaných derivátov difenylu; je napríklad možné spájať deriváty kyseliny fenylboritej s ary 1 ha 1ogeni dm i s použitím katalyzátorov zo skupiny prechodových kovov, napríkl ad ρa ládia. Príslušné reakcie opísal napríklad R. B. Miller so sp. v Organometallics, 1984, 3, 1261 alebo A.Zuzuki so sp., Synthetic Commun. 11 /7/, 513 /1981/.To date, various processes for the production of substituted diphenyl derivatives have been described; it is possible, for example, to combine phenylboronic acid derivatives with aryl and halogenated catalysts using transition metal catalysts, e.g. Appropriate reactions have been described, for example, by R. B. Miller et al. in Organometallics, 1984, 3, 1261 or A.Zuzuki et al., Synthetic Commun. 11 (7), 513 (1981).

Podstata vynálezuSUMMARY OF THE INVENTION

Vynález sa týka spôsobu výroby derivátov difenylu všeobecného vzorca IThe invention relates to a process for the preparation of diphenyl derivatives of the general formula I

v ktorom in which X X je poprípade chránená formylová alebo -CH/ORΊ/OR2,where appropriate, formyl or -CH / OR Ί / OR 2 is protected, skupina, group, najmä -CHO especially -CHO R 1 , R2 R 1, R 2 nezávisle na sebe značia alkylovú skupinu tómami uhlíka alebo R1 a R2 spolu dovedna kylénový reťazec -/CHs/n-, pričom n je ce 3, 4, alebo 5, aindependently of one another denotes an alkyl group with carbon atoms or R @ 1 and R @ 2 together represent a cylene chain - (CH3) n -, wherein n is 3, 4, or 5, and s 1 až 6 atvoria a 1 - 1 é číslo 2, with 1 to 6 atoms and 1 - 1 é number 2, R R značí zoskupenie, ktoré je samo reakčným podmienkam pri syntéze. denotes a moiety which is itself the reaction conditions in the synthesis. o sebe inertné proti inert against themselves Pr i At spôsobe podľa tohto vynálezu sa the method of the invention is vychádza is based od známych, from friends,

poprípade chránených formy1 feny1 ha 1ogenidov, napríklad bromidov alebo jodidov a pomocou Grignardovej reakcie sa dospeje k derivátom kyseliny boritej /viď napríklad H. Feulner so sp., Chemische Berichte 123, 1990 , 1841 až 1843/ všeobecného vzorca IIoptionally protected forms of phenyl halides, for example bromides or iodides, and boronic acid derivatives are obtained by Grignard reaction (see, for example, H. Feulner et al., Chemische Berichte 123, 1990, 1841-1843) of formula II

XX

I /11/,I / 11 /,

YY

Ξ0 0Ξ v ktorom substituent X značí skupinu -CHO alebo príslušne chránenú formylovú skupinu, napríklad acetálovú. Zlúčeniny všeobecného vzorca II sa potom kopuláciou so substituovanými fenylhalogenidmi všeobecného vzorca IIIKtorom O 0Ξ wherein the substituent X represents a -CHO group or an appropriately protected formyl group, for example acetal. The compounds of formula II are then coupled with substituted phenyl halides of formula III

ktoré je možné získať známymi metódami, prevádzajú na zlúčeniny dífenylu všeobecného vzorca I, pričom ako ha 1ogén s kupiny /Hal / u zlúčenín všeobecného vzorca III prichádzajú do úvahy predovšetkým bromiay alebo jodidy, s výhodou najmä bromidy; a R má vyššie definovaný význam.which can be obtained by known methods, are converted to the diphenyl compounds of the formula (I), in particular bromides or iodides, preferably in particular the bromides; and R is as defined above.

Namiesto derivátov kyseliny boritej všeobecného vzorca II môžu byť pri spôsobe podľa vynálezu použité aj zodpovedajúce estery kyseliny boritej, ktoré môžu byť syntetizované z derivátov kyseliny bróm-mety1 feny1 bor itej , slúžiacich ako východz i e 1átky.Instead of the boronic acid derivatives of the formula II, the corresponding boronic esters can also be used in the process according to the invention, which can be synthesized from the bromomethyl phenyl boronic acid derivatives which serve as starting materials.

Spojenie oboch feny1 der ivátov všeobecných vzorcov II a III do potrebnej zodpovedajúcej zlúčeniny difenylu sa môže uskutočniť s použitím katalyzátora, s výhodou paládiového katalyzátora. Reakčné podmienky môžu byť obmieňané podľa reaktivity východzích látok, prednosť má rozpätie teplôt od 20 až do 150 °C a tlak od 133 äž po 665 Pa. Ako rozpúšťadlá prichádzajú do úvahy napríklad zmesi benzénu alebo toluénu s alkoholmi, najmä s etanolom.The coupling of the two phenyl derivatives of formulas II and III to the corresponding corresponding diphenyl compound can be carried out using a catalyst, preferably a palladium catalyst. The reaction conditions may be varied according to the reactivity of the starting materials, with a temperature range of from 20 to 150 ° C and a pressure of from 1 to 1 bar. Suitable solvents are, for example, mixtures of benzene or toluene with alcohols, in particular ethanol.

Ako substituenty R, v zlúčeninách všeobecného vzorca I prichádzajú do úvahy všetky také zoskupenia, ktoré sa nemenia ani za reakčných podmienok, používaných k spojeniu oboch benzénových jadier. Ako substituenty R sú vhodné najmä tieto skupiny: R značí atóm fluóru, chlóru, n i t ros kupinu, zoskupenieSuitable substituents R in the compounds of the formula I are all those moieties which do not change even under the reaction conditions used to join the two benzene nuclei. The following groups are particularly suitable as substituents R: R represents a fluorine atom, a chlorine atom, a nitro group, an

-/CHsA-COOR3 , -/CHc/m-C0NHR3 , -/CHc/m-CN, -SO2NH-COOR3, -SO2NH-CO-NHR3, -SO = NH-SO2-R 3 , -NHSO2R3,- / ChSA -COOR 3, - / CHCl / m C0NHR 3, - / CHCl / m -CN, -SO 2 NH-COOR 3, -SO 2 NH-CO-NHR 3, -SO -NH-SO 2 R 3, -NHSO 2 R 3 ,

N-N /OXN - trityl, -POaR3, -NH-SO=-CF3 alebo -SOeNR“, '''N pričom R3 značí atóm vodíka alebo alkylovú skupinu s 1 až 6 atómami uhlíka, cyk 1oa1ky1ovú skupinu s 3 až 6 atómami uhlíka alebo cyk 1oa1ky1ovú skupinu s 3 až 6 atómami uhlíka, ktorá je substituovaná alkylovou skupinou s 1 až 6 atómami uhlíka aNN / N O O - trityl, -POaR 3, -NH-SO 3 or -CF = -SOeNR '''' N wherein R 3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, cycloalkyl having 3 1oa1ky1ovú or (C 3-C cyk) cycloalkyl group substituted with (C až-C alky) alkyl; and

R4 je skupina =0-Ν/0Η3/= , m je celé číslo 0, 1, 2, 3 alebo 4.R 4 is = O-Ν (0-3) =, m is an integer of 0, 1, 2, 3 or 4.

Namiesto spájania systémov oboch feny1 der ivátov cez derivát kyseliny boritej je tiež možná príprava derivátov difenylu všeobecného vzorca I s použitím halogénfenyl- či metylfenylderivátov zinku alebo cínu alebo Grignardových zlúčenín.Instead of linking both phenyl derivative systems via a boronic acid derivative, it is also possible to prepare diphenyl derivatives of formula I using zinc or tin halophenyl or methyl phenyl derivatives or Grignard compounds.

Prípravu chránených formylových zoskupení a Grignardových zlúčenín je možné realizovať bežnými metódami. .The preparation of protected formyl moieties and Grignard compounds can be accomplished by conventional methods. .

Vynález sa tak isto týka zlúčenín všeobecného vzorca I ako takých, pričom prednosť majú tie zlúčeniny, u ktorých R značí SO2NHCOOR3, SOzNHCONHR3, SO = NHSO = R3 alebo SOcNR“, kde sú obzvlášť výhodné skupiny SO2NHCONHR3 a SO2NR4; ďalej sa týka zlúčenín všeobecného vzorca III ako takých, pričom sú výhodné tie zlúčeniny, u ktorých R značí skupiny SO2NH-COOR3, SO2NH-CO-NHR3 alebo SO2NH-SO2R3, pričom skupina SO2NHCONHR3 je mimoriadne výhodná.The invention also relates to compounds of formula I as such, with preference given to those compounds in which R is SO 2 NHCOOR 3 , SO 2 NHCONHR 3 , SO = NHSO = R 3, or SOcNR ", where SO 2 NHCONHR 3 and SO 2 NR 4 are particularly preferred; furthermore, it relates to compounds of formula III as such, with those compounds in which R is SO 2 NH-COOR 3 , SO 2 NH-CO-NHR 3 or SO 2 NH-SO 2 R 3 , with SO 2 NHCONHR 3 being particularly preferred.

Nasledujúce príklady prevedenia vynález bližšie ilustrujú.The following Examples illustrate the invention.

Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION

Príklad 1Example 1

Spôsob výroby 4-formyl-2'-N,N-dimetylaminoformyl-difenylsulfonamidu vzorcaProcess for preparing 4-formyl-2'-N, N-dimethylaminoformyl-diphenylsulfonamide of the formula

CHOCHO

1a/ 4-Brómbenzaldehyd-dietylacetál1a / 4-Bromobenzaldehyde diethyl acetal

K roztoku 2,7 g /1,1 mol/ dusičnanu amónneho v 65 ml bezvodného etanolu sa pridá 100 g /0,54 mol/ roztaveného 4-brómbenzaldehydu a 90 ml /0,54 mol/ triety1esteru kyseliny ortomravčej. Po 18 hodinách pri teplote miestnosti sa reakčná zmes sfiltruje a zalkalizuje piperidínom /asi pH 10/. Titulná zlúčenina sa získa destiláciou vo vákuu.To a solution of 2.7 g (1.1 mol) ammonium nitrate in 65 ml anhydrous ethanol was added 100 g (0.54 mol) molten 4-bromobenzaldehyde and 90 ml (0.54 mol) triethyl orthoformate. After 18 hours at room temperature, the reaction mixture was filtered and made basic with piperidine (about pH 10). The title compound is obtained by distillation in vacuo.

Výťažok 90 % teórie;Yield 90% of theory;

teplota varu /pri 6,6 Pa/ = 110 až 115 °C.boiling point (at 6.6 Pa) = 110-115 ° C.

1b/ 4-Formy 1 feny1 bor i tá kyselina1b / 4-Form 1 phenyl boronic acid

V atmosfére argónu sa 3,65 g horčíkových hoblín prevrství ml bezvodného tetrahydrofuránu a pridá sa 0,5 ml 1, 2-dibrómetánu. Po miernom zahriatí nastane prudká reakcia. Po jej odoznení sa pomocou pipety rozpúšťadlo odtiahne, pridá sa 40 ml bezvodného tetrahydrofuránu a 1/3 roztoku produktu z príkladu 1a/ v 30 ml bezvodného tetrahydrofuránu. Reakcia sa naštartuje pomocou prídavku Red-Al /viď vysvetlivky za príkladmi/ a zahriatím. Zvyšok produktu z príkladu 1a/ sa teraz prikvapkáva v priebehu 35 min. Po ukončení prikvapkávania sa ešte 1 h varí pod spätným chladičom. Grignardovo činidlo sa potom v atmosfére argónu pri kvapká k roztoku 33,5 ml tributylborátu v 50 ml tetrahydrofuránu, ochladenému na -68 °C. Po 30 min sa chladenie odstráni. Zmes sa mieša 1 h pri teplote miestnosti, potom sa odparí, medovo sfarbený olej sa vyberie do 100 ml éteru a pridá sa 80 ml /1 M/ ľadovo studenej kyseliny sírovej. Éterická vrstva sa oddelí, zvyšok sa extrahuje ešte dvakrát po 500 ml éteru; odparí sa a pridáva sa 30% /6 N/ roztok hydroxydu draselného až do dosiahnutia alkalickej reakcie /pH 14/. Pridá sa 70 ml vody a vo vysokom vákuu sa pri 35 až 40 °C odstráni azeotropno butanol. Tento postup sa opakuje ešte raz s 50 ml vody. Odparok sa okyslí 1 M kyselinou sírovou /pH 1/ a 30 min sa varí. Po filtrácii sa získa titulná zlúčenina v podobe svetložltej pevnej látky.Under an argon atmosphere, 3.65 g of magnesium shavings were overlaid with ml of anhydrous tetrahydrofuran and 0.5 ml of 1,2-dibromoethane was added. After a slight heating, a violent reaction occurs. After removal of the solvent, the solvent is removed by pipette, 40 ml of anhydrous tetrahydrofuran and 1/3 of the solution of the product of Example 1a / in 30 ml of anhydrous tetrahydrofuran are added. The reaction is started by the addition of Red-Al (see explanatory notes after the examples) and heating. The remainder of the product of Example 1a) is now added dropwise over 35 min. After completion of the dropwise addition, the mixture is refluxed for 1 hour. The Grignard reagent was then added dropwise to a solution of 33.5 mL of tributyl borate in 50 mL of tetrahydrofuran cooled to -68 ° C under argon. After 30 min, the cooling was removed. The mixture was stirred at room temperature for 1 h, then evaporated, the honey-colored oil was taken up in 100 mL of ether and 80 mL (1 M) of ice-cold sulfuric acid was added. The ether layer was separated, the residue was extracted twice more with 500 ml of ether each time; Evaporate and add 30% (6 N) potassium hydroxide solution until alkaline (pH 14). 70 ml of water are added and azeotropic butanol is removed under high vacuum at 35-40 ° C. This procedure is repeated once more with 50 ml of water. The residue is acidified with 1 M sulfuric acid (pH 1) and boiled for 30 min. Filtration gave the title compound as a pale yellow solid.

Teplota topenia - 255 až 260 ”C.Melting point - 255-260 ° C.

1c/ 4-Formyl-2'-N,N-dimetylaminoformyl-difenylsulfonamid1c / 4-Formyl-2'-N, N-dimethylaminoformyl-diphenylsulfonamide

K roztoku 7 g /0,024 mol/ 2-bróm-N,N-dimetylaminoformylbenzénsulfonamidu a 0,7 g t r i feny 1 fosfínu /0,1 ekvivalentu/ v 100 ml toluénu sa pridá za tepla roztok 5,7 g uhličitanu sodného /2 ekvivalenty/ v 30 ml vody. Dobre sa vypláchne argónom a pri 60 °C sa pridá v prúde argónu 0,3 g octanu paladna tého /0,05 ekvivalentu/. Po 10 ku, ktorý sa medzitým sfarbil zlúčeniny z príkladu 1b/ /1,1 opäť v atmosfére argónu. Potom minútach sa k reakčnému roztočiernohnedo, pridá roztok 4 g ekvivalentu/ v 70 ml etanolu, sa reakčná zmes zahreje až na teplotu varu a varí sa 3,5 hodiny pod spätným chladičom. Po ochladení sa rozpúšťadlo odstráni vo vákuu. Odparok sa vyberie do 150 metylacetátu a 5 x premyje nasýteným roztokom uhličitanu sodného. Organická fáza sa vysuší síranom horečnatým a sfiltruje cez vrstvu kremeliny. Po odparení rozpúšťadla vo vákuu sa získa 8 g. titulnej zlúčeniny v podobe hnedej, čiastočne kryštalickej surovej substancie. Dá sa vyčistiť vyvarením asi s 30 ml etylacetátu.To a solution of 7 g (0.024 mol) of 2-bromo-N, N-dimethylaminoformylbenzenesulfonamide and 0.7 g of triphenylphosphine (0.1 equivalent) in 100 ml of toluene is added a solution of 5.7 g of sodium carbonate (2 equivalents) while warm. in 30 ml of water. It is purged well with argon and 0.3 g of palladium (II) acetate (0.05 equivalents) is added at 60 ° C in an argon stream. After 10 ke, which in the meantime stained the compounds of Example 1b / 1.1 again under argon. Thereafter, a solution of 4 g equivalent / in 70 ml of ethanol was added to the reaction mites, brown, heated to reflux and refluxed for 3.5 hours. After cooling, the solvent was removed in vacuo. The residue is taken up in 150 methyl acetate and washed 5 times with saturated sodium carbonate solution. The organic phase is dried over magnesium sulphate and filtered through a pad of diatomaceous earth. Evaporation of the solvent in vacuo gave 8 g. of the title compound as a brown, partially crystalline crude substance. It can be purified by boiling with about 30 ml of ethyl acetate.

Výťažok 83 % teórie;Yield: 83%.

Rf = 0,4 /E/H 2/1/; MS /M + 1 / = 317; Rf = 0.4 / E / H 2/1 /; MS (M + 1) = 317;

teplota topenia = 161 °C.mp = 161 ° C.

Analogicky, ak sa použijú príslušné východzie látky, je možné pripraviť zlúčeniny z príkladov 2 až 6. Ich štruktúra a fyzikálne údaje sú uvedené v tabuľke 1.Analogously, using the appropriate starting materials, the compounds of Examples 2 to 6 can be prepared. Their structure and physical data are shown in Table 1.

t á t u sa získa titulná zlúčenina.This gave the title compound.

Rf = 0,5 /E/H 2/1/ MS /M + 1 / = 321.R f = 0.5 (E / H 2/1 / MS (M + 1) = 321).

Príklad 8Example 8

Spôsob výroby 2-jódfeny1-n-propy1su1 fony 1 močov inyProcess for the preparation of 2-iodophenyl-n-propylsulphonyl urea

8a/ 2-JódbenzénsuIfonamid8a / 2-Iodobenzenesulfonamide

Zmes 3,5 g 2-aminobenzénsulfonamidu a 25 ml kone, kyseliny sírovej /98%/ sa zahrieva na 60 °C tak dlho, až vznikne číry roztok a prídavkom 20 g ľadu sa ochladí na 0 °C. Potom sa opatrne prikvapkáva roztok 1,45 g dusitanu sodného v 4 ml vody tak, aby teplota nepresiahla 5 až 6 °C a ďalej sa reakčná zmes mieša pri 5 až 6 °C po dobu 3 hodín. Po prikvapkaní roztoku 3,75 g jodidu draselného v 25 ml vody sa vzniknutá červená zmes opäť mieša 18 hodín. Po prídavku 50 ml vody sa vzniknutá zrazenina odfiltruje a niekoľkokrát premyje vodou. Získaná pevná látka sa rozpustí v etylacetáte, premyje raz 0,2 N roztokom tiosíranu sodného a dvakrát vodou a rozpúšťadlo sa odparí. Získajú sa 4 g ľahko nažltlej substancie.A mixture of 2-aminobenzenesulfonamide (3.5 g) and sulfuric acid (25 ml) of horse (98%) was heated to 60 ° C until a clear solution was formed and cooled to 0 ° C by the addition of 20 g of ice. A solution of 1.45 g of sodium nitrite in 4 ml of water is then carefully added dropwise such that the temperature does not exceed 5-6 ° C and the reaction mixture is further stirred at 5-6 ° C for 3 hours. After the dropwise addition of a solution of 3.75 g of potassium iodide in 25 ml of water, the resulting red mixture was again stirred for 18 hours. After addition of 50 ml of water, the precipitate formed is filtered off and washed several times with water. The solid obtained was dissolved in ethyl acetate, washed once with 0.2 N sodium thiosulfate solution and twice with water, and the solvent was evaporated. 4 g of slightly yellowish substance are obtained.

Výťažok 62 % teórie;Yield 62% of theory;

IČ /nujol/: 3360, 3255, 1562 cm-1; MS /M*/: 283;IR (nujol): 3360, 3255, 1562 cm @ -1 ; MS (M +): 283;

teplota topenia = 197 až 198 °C.mp = 197-198 ° C.

8b/ 2-Jódfenyl-n-propylsulfonylmočovina8b) 2-Iodophenyl-n-propylsulfonylurea

K roztoku 4 g 2-jódbenzénsu1 fonamidu v 40 ml acetónu sa za miešania pridá naraz 3,92 g pevného uhličitanu draselného a zmes sa varí ďalej v atmosfére dusíka pod spätným chladičom. K horúcej reakčnej zmesi sa prikvapká n-propy1 izokyanát, potom sa varí 2 hodiny pod spätným chladičom, ochladí na teplotu miestnosti a odparí k suchu. Po prídavku 200 ml vody sa ochladená reakčná zmes okyslí 2 N kyselinou chlorovodíkovou na pH 4 a sfiltruje. Zrazenina sa p rekr y šta 1 u je zo zmesi acetónu s izopropy1 éterom a získa sa titulná zlúčenina, výťažok 4,1 g.To a solution of 4 g of 2-iodobenzenesulfonamide in 40 ml of acetone, 3.92 g of solid potassium carbonate are added in one portion with stirring, and the mixture is further refluxed under nitrogen. The n-propyl isocyanate is added dropwise to the hot reaction mixture, then refluxed for 2 hours, cooled to room temperature and evaporated to dryness. After addition of 200 ml of water, the cooled reaction mixture is acidified to pH 4 with 2N hydrochloric acid and filtered. The precipitate was recrystallized from acetone / isopropyl ether to give the title compound, yield 4.1 g.

IČ /nujol/: 3406, 3368, 1715, 1565, 1539 cm-1;IR (nujol): 3406, 3368, 1715, 1565, 1539 cm @ -1 ;

MS /M*/: 368;MS (M +): 368;

teplota topenia = 211 až 212 °C.mp = 211-212 ° C.

Údaje o titulných zlúčeninách z príkladov prevedenia č. 1, 2, 3, 5, 8a/ a 8b/ , získané pri 1H-N M R, sú zhrnuté v tabuľke 2.Data on the title compounds of the embodiment no. 1, 2, 3, 5, 8a (and 8b) obtained at 1 HN MR are summarized in Table 2.

Tabuľka 2Table 2

1 : 1: /DMSO-de/ / DMSO-d / d = 2,68 /s, 3 H/; d d = 2.68 (s, 3H); D = 2,72 /S, 3 H/; = 2.72 (S, 3H); d = 7,2 d = 7.2 /s, 1 H/; (s, 1H); d = 7,25 až 7,35 /m, d = 7.25 to 7.35 / m, 1 H/; d = 7,45 až 1 H /; d = 7.45 to 7,75 7.75 /M, 4 H/; (M, 4 H); d = 7,95 /d, J = 8 Hz d = 7.95 / d, J = 8Hz , 1 H/; d = 8,05 1 H; d = 8.05 a z 8,15 and from 8.15 /M, 2H/; d (M, 2H); D = 10,1 /S, 1 H/, = 10.1 (S, 1H), Λ . ú · Λ. ú · /CDCls/ d / CDCls / d =1,0 /t, J = 7 Hz, 3 = 1.0 / t, J = 7Hz, 3 H/; d = 4,1 /q, H /; d = 4.1 / q J = 7 Hz , J = 7Hz,

H/; d = 7,3 až 7,'6 /m, 5 H/; d = 7,85 až 8,0 /m, 3 H/; d = 10,1 /S, 1 H/.H /; d = 7.3-7.6 (m, 5H); d = 7.85 to 8.0 (m, 3H); d = 10.1 (S, 1H).

3: 3: /CDCls/ d = 7,2 až 7,8 /m, 6 H/; 7,95 až 8,05 /m, 2H/; d = 10,1 /S, 1H/. (CDCl 3) d = 7.2-7.8 (m, 6H); 7.95 to 8.05 (m, 2H); d = 10.1 (S, 1H). 5: 5: /DMSO-de/ d = 1,0 /t, J = 7 Hz, 3 H/; d = 1,3 / dq, J = = 7 Hz, 2 H/; d = 2,85 /dd, , J = 7 Hz, J = 9,5 Hz, 2 H/; d = 6,1 /t, J = 7 Hz, 1 H/; d = 7,1 až 7,4 /m, 1 H/; d = = 7,4 až 7,8 //m, 4 H/; d = 7,9 až 8,1 /m, 3 H/; d = 9,9 /s, 1 H/; d = 10,1 /s, 1 H/. (DMSO-d 6) d = 1.0 (t, J = 7 Hz, 3 H); d = 1.3 / dq, J = = 7 Hz, 2H; d = 2.85 (dd, J = 7 Hz, J = 9.5 Hz, 2H); d = 6.1 (t, J = 7 Hz, 1H); d = 7.1 to 7.4 (m, 1H); d = = 7.4 to 7.8 (m, 4H); d = 7.9-8.1 (m, 3H); d = 9.9 (s, 1H); d = 10.1 (s, 1H). 8a/: 8 /: /CDClä/ 5,17 /s, I, NH=/; 7,23 až 7,52 /td aromáty 2H/; 8,08 až 8,20 /dd, aromáty 2 H/.(CDCl 3) 5.17 (s, I, NH = ); 7.23 to 7.52 (td aromatics 2H); 8.08 to 8.20 (dd, aromatics 2H). 8b/: 8b /: /CDCls/ 0,82 /t, J = 7,5 CHs, 3 H/; 1,45 /m, CH=, 2 H; 3,14 /m, CHs, 2 H/; 6,39 /t, CONH, 1 H/; 7,29 /dt, J = = 1,5 aromáty/; 7,54 /td, J = 8,15 aromáty/; 8,13 /m, aromáty/; 7,59 /s, SOsNH, 1 H/. (CDCl 3) 0.82 (t, J = 7.5 CH 3, 3 H); 1.45 / m, CH = 2H; 3.14 (m, CH3, 2H); 6.39 (t, CONH, 1H); 7.29 (dt, J = 1.5 aromatics); 7.54 (td, J = 8.15 aromatics); 8.13 (m, aromatics); 7.59 (s, SOsNH, 1H).

Vysvetlivky skratiek:Abbreviations:

E = etylacetátE = ethyl acetate

H = n-heptár>H = n-heptar>

Red-Al - nátrium-dihydrido-bis-/2-metoxy-etoxy/a 1 um inátRed-Al-sodium dihydrido-bis- (2-methoxy-ethoxy) and 1 µminate

Trityl = tri fenyImety1Trityl = three bitches

Priemyselná využiteľnosťIndustrial usability

Zlúčeniny, ktoré je možné pripravovať spôsobom podľa tohoto vynálezu, sú dôležitými medziproduktami pre výrobu liečiv znižujúcich krvný tlak, najmä antagonistov receptorov angiotenzínu II.The compounds that can be prepared by the process of this invention are important intermediates for the production of blood pressure lowering drugs, especially angiotensin II receptor antagonists.

οοο6-%οοο6-%

Claims (9)

PATENTOVÉ NÁROKYPATENT CLAIMS 1. Spôsob výroby zlúčeniny všeobecného vzorca I /V, v ktoromA process for producing a compound of formula I / V, wherein: X je poprípade chránená formylová skupina a R značí skupinu, ktorá je sama o sebe inertná voči reakčným podmienkam pri syntéze, vyznačený tým, že sa zlúčenina všeobecného vzorca II /H/, v ktorom X má vyššie uvedený význam, uvádza do reakcie so substituovanou feny1 ha 1ogénz1účeninou všeobecného vzorca IIIX is optionally a protected formyl group and R is a group which is itself inert to the reaction conditions in the synthesis, characterized in that the compound of formula II (H) in which X is as defined above is reacted with a substituted phenyl group. and h) a compound of formula III Hal v ktorom substituent Hal značí ha 1cgénskupinu a R má vyššie uvedený význam.Hal wherein Hal is halo and R is as defined above. 2. Spôsob podľa nároku 1, vyznačený tým, že vo všeobecnom vzorci I majú substituenty tento význam:Process according to Claim 1, characterized in that in formula I the substituents have the following meanings: R2 je skupina -CHO alebo -CH/OR 1/OR =, nezávisle na sebe značia atómami uhlíka alebo R1 a kylénový reťazec -/CH.>/r>-,R 2 is -CHO or -CH / OR 1 / OR = , independently of one another is C or R 1 and the cylene chain - (CH 2) -, 3 , 4 alebo S, značí atóm fluóru, chlóru, -/CHc/m-COOR3, -/CHs/m-CONHR“ -SO=NH-COOR3, -SOzNH-CO-NHR3, alkylovú skupinu s 1 až 6 R2 spolu dovedna tvorí a 1 príčom n je celé číslo 2,3, 4 or S, denotes fluorine, chlorine, - (CH 3) m -COOR 3 , - (CH 3) m -CONHR 3 -SO = NH-COOR 3 , -SO 2 NH-CO-NHR 3 , an alkyl group having 1 to 3 6 R 2 together skillfully form and 1 cause n is the integer 2, -nitroskupinu, zoskupenie-nitro grouping R3, -/CHs/m-CN,R 3, - / CH / m-CN, -SO=NH-SO=R3,-SO = NH-SO = R 3 -NHSO2R3,-NHSO2R 3 , N-N /q N -trityl, -PO3R3, -NH-SO — CF3 alebo -SO = NR4, pričom R3 značí atóm vodíka s 1 až 6 atómami uhlíka, cyk 1oa1 k y 1 ov ú skupinu 6 atómami uhlíka, cykloalkylovú skupinu s 3 až mami uhlíka, ktorá je substituovaná alkylovou nou s 1 až 6 atómami uhlíka a alebo a 1 k y 1 o v ú skupinu s 3 ažNN / q N -trityl, -PO 3 R 3 , -NH-SO-CF 3 or -SO = NR 4 , wherein R 3 represents a hydrogen atom having 1 to 6 carbon atoms, a cyclic group having 6 carbon atoms a (C 3 -C 6) cycloalkyl group which is substituted by a (C 1 -C 6) alkyl group or a (C 3 -C 6) alkyl group 6 atóskup i R4 je skupina =C-N/CH2/= , m je celé číslo 0, 1, 2, 3 alebo 4.And R 4 is = CN (CH 2 ) = , m is an integer of 0, 1, 2, 3 or 4. •Spôsob podľa nároku 1, v y z n a č e reakcia zlúčeniny všeobecného vzorca II so ného vzorca III uskutočňuje v prítomnosti zátora zo skupiny prechodových kovov.The process according to claim 1, wherein the reaction of the compound of formula (II) with the compound of formula (III) is carried out in the presence of a transition metal group. 3.Third že sathat is 4. Zlúčenina všeobecného vzorca I n ý tým, zlúčeninou všeobecpaládia ako kataly/1/, v ktorom majú substituenty tento význam:4. A compound of formula (I), wherein the palladium compound is a catalyst (1) in which the substituents have the following meanings: X je skupina -CHO alebo -CH/ORΊ/OR2 ,X is -CHO or -CH / OR 2 / OR 2 R1, R2 nezávisle na sebe značia alkylovú skupinu s 1 až 6 atómami uhlíka alebo R1 a R2 spolu dovedna tvoria alkylénový reťazec -/CH-/n-, pričom n je celé číslo 2,3,4aleboR 1 , R 2 independently of each other denote an alkyl group having 1 to 6 carbon atoms, or R 1 and R 2 together form an alkylene chain - / CH - / n -, where n is an integer of 2,3,4 or 5,5 R značí atóm fluóru, chlóru, nitroskupinu, zoskupenieR represents a fluorine atom, a chlorine atom, a nitro group, a moiety -/CHa/m-COOR3 , -/CH2/m-CONHR3, -/CHs/m-CN, -SO2NH-COOR3 , -SO2NH-CO-NHR3, -SO2 NH-SO2 R 3 , -NHSO2R3,- / CH 2 / m-COOR 3 , - (CH 2) m -CONHR 3 , - (CH 3) m-CN, -SO 2 NH-COOR 3 , -SO 2 NH-CO-NHR 3 , -SO 2 NH-SO 2 R 3 , -NHSO 2 R 3 , N-N ¢0 N -trityl, -PO3R3, -NHSOz-CFa alebo -SO^NR“, N pričom R3 značí atóm vodíka alebo alkylovú skupinu s 1 až 6 atómami uhlíka, cyk 1oa1 k y 1 ovú skupinu s 3 až 6 atómami uhlíka, cykloalkylovú skupinu s 3 ažNN ¢ 0 N -trityl, -PO 3 R 3 , -NHSO 2 -Ca or -SO 2 NR 3 , N wherein R 3 represents a hydrogen atom or a C 1 -C 6 alkyl group, a C 3 -C 6 cycloalkyl group C 3 -C 3 cycloalkyl 6 atómami uhlíka, ktorá je substituovaná alkylovou6 carbon atoms which is substituted by alkyl skupinou s 1 až 6 atómami uhlíka C 1 -C 6 a and R4 je skupina =C-N/CH3 R 4 is = CN / CH 3 / = > / => m je celé číslo 0, 1, m is an integer of 0, 1, 2, 3 alebo 2, 3 or 4. 4th 5 . 5. Zlúčenina podľa nároku 4 v A compound according to claim 4 in y z n a č y z n and no e n á e n á t ý t ý m, že m that vo within všeobecnom vzorci I of formula R R značí zoskupenie -S02- indicates group -SO2- NRn alebo -NR n or - SC2NHCONHR3 SC2NHCONHR 3 pr í čom why R3 je atóm vodíka alebo alkylováR 3 is hydrogen or alkyl skupina group s 1 s 1 až 6 a- up to 6 a-
tómami uhlíka acarbon atoms and Rd je skupina = C-N/CH3/2.R d is = CN / CH3 / second 6. Použitie zlúčeniny, pripravenej podľa niektorého z nárokov 1 až 4, ako medzi produktu pre syntézu účinných látok.Use of a compound prepared according to any one of claims 1 to 4 as an intermediate for the synthesis of active substances.
7 . Použitie zlúčeniny podľa niektorého z nárokov 4 alebo 5 ako medzi produktu pre syntézu antagonistov receptorov angiotenzínu II.7. Use of a compound according to any one of claims 4 or 5 as an intermediate product for the synthesis of angiotensin II receptor antagonists. 8. Zlúčenina všeobecného vzorca IIIA compound of formula III Hal v ktorom substituenty majú tento význam:Hal in which the substituents have the following meaning: Ή31 značí atóm brómu alebo jódu,Ή31 denotes a bromine or iodine atom, R značí zoskupenie -SO2NH-COOR3, -SO2NH-CO-NHR3,R is -SO 2 NH-COOR moiety 3, -SO 2 NH-CO-NHR 3, -S0=NH-SOo-R3, pričom R3 je atóm vodíka, alkylová skupina s 1 až 6 atómami uhlíka, cyk 1oa1ky1ová skupina s 3 až 6 atómami uhlíka alebo cyk 1oa1ky1ová skupina s 3 až 6 atómami uhlíka, ktorá je substituovaná alkylovou skupinou s 1 až 6 atómami uhlíka.-SO = NH-SO 0 -R 3 wherein R 3 is hydrogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl or C 3 -C 6 cycloalkyl substituted with alkyl C 1 -C 6. 9. Zlúčenina podľa nároku 8, v y z n a č e n á t ý m, že vo všeobecnom vzorci III substituent R značí zoskupenie -SO2NH-CO-NHR3, v ktorom R3 značí alkylovú skupinu s 1 až 6 atómami uhlíka.Compound according to claim 8, characterized in that in formula III, R represents a group -SO 2 NH-CO-NHR 3 in which R 3 represents an alkyl group having 1 to 6 carbon atoms.
SK6-94A 1993-01-06 1994-01-04 Process for the preparation of diphenyl derivatives SK694A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4300137 1993-01-06

Publications (1)

Publication Number Publication Date
SK694A3 true SK694A3 (en) 1994-08-10

Family

ID=6477764

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6-94A SK694A3 (en) 1993-01-06 1994-01-04 Process for the preparation of diphenyl derivatives

Country Status (25)

Country Link
US (2) US5618975A (en)
EP (1) EP0606065B1 (en)
JP (1) JP3586288B2 (en)
KR (1) KR940018349A (en)
CN (1) CN1096511A (en)
AT (1) ATE183732T1 (en)
AU (1) AU677247B2 (en)
BR (1) BR9400018A (en)
CA (1) CA2112795A1 (en)
CZ (1) CZ1494A3 (en)
DE (1) DE59408646D1 (en)
DK (1) DK0606065T3 (en)
ES (1) ES2136669T3 (en)
FI (1) FI940032A7 (en)
GR (1) GR3031852T3 (en)
HR (1) HRP940001A2 (en)
HU (1) HUT67406A (en)
IL (1) IL108262A0 (en)
NO (1) NO301878B1 (en)
NZ (2) NZ250577A (en)
PL (1) PL301778A1 (en)
SI (1) SI9400003A (en)
SK (1) SK694A3 (en)
TW (1) TW348175B (en)
ZA (1) ZA9418B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874593A (en) * 1994-05-16 1999-02-23 Sumitomo Chemical Company, Limited Production process and intermediate of tetrazole compound
FR2737721B1 (en) 1995-08-08 1997-09-05 Roussel Uclaf NOVEL BIPHENYL COMPOUNDS, THEIR PREPARATION METHOD AND INTERMEDIATES THEREOF, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA001071B1 (en) * 1996-03-13 2000-10-30 Басф Акциенгезельшафт Process for preparing nitrobiphenylene
KR19990069877A (en) * 1998-02-13 1999-09-06 성재갑 Cyclin-dependent kinase inhibitor compound with naphthoquinone structure
DE102005022362B4 (en) * 2005-05-10 2016-12-15 Studiengesellschaft Kohle Mbh Process for the decarboxylative C-C linkage of carboxylic acids with carbon electrophiles
US9051656B2 (en) * 2009-07-23 2015-06-09 Ceramatec, Inc. Electrochemical synthesis of aryl-alkyl surfacant precursor
US9957622B2 (en) 2009-07-23 2018-05-01 Field Upgrading Limited Device and method of obtaining diols and other chemicals using decarboxylation
US8647492B2 (en) 2009-07-23 2014-02-11 Ceramatec, Inc. Method of producing coupled radical products from biomass
US20110024288A1 (en) * 2009-07-23 2011-02-03 Sai Bhavaraju Decarboxylation cell for production of coupled radical products
US9206515B2 (en) 2009-07-23 2015-12-08 Ceramatec, Inc. Method of producing coupled radical products via desulfoxylation
US9493882B2 (en) 2010-07-21 2016-11-15 Ceramatec, Inc. Custom ionic liquid electrolytes for electrolytic decarboxylation
ES2685783T3 (en) 2010-08-05 2018-10-11 Field Upgrading Limited Method and device for the production of carboxylic acid
US8853463B2 (en) 2011-01-25 2014-10-07 Ceramatec, Inc. Decarboxylation of levulinic acid to ketone solvents
EP2668250B1 (en) 2011-01-25 2019-04-24 Enlighten Innovations Inc. Production of fuel from chemicals derived from biomass
JP7023080B2 (en) 2016-10-31 2022-02-21 東ソー株式会社 Method for producing aromatic compounds
PL3820839T3 (en) * 2018-09-25 2024-04-08 Arxada Ag Method for preparation of potassium 5-iodo-2-carboxybenzene sulfonate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624142A (en) * 1964-09-10 1971-11-30 Merck & Co Inc Substituted biphenyl acetic acid derivatives
DE2362589A1 (en) * 1973-12-17 1975-07-10 Thomae Gmbh Dr K Antiphlogistic phenyl-alkyl or alkenyl ketones or carbinols - have superior activity to phenylbutazone and are used in arthritis and rheumatism treatment
ATA937274A (en) * 1973-12-17 1978-02-15 Thomae Gmbh Dr K PROCESS FOR PRODUCING NEW ARALIPHATIC KETONES
US5068424A (en) * 1988-06-17 1991-11-26 Nitrokemia Ipartelepek Process for preparing arylsulphonyl-isocyanates and addition derivatives thereof
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
FR2659655B1 (en) * 1990-03-19 1992-07-24 Union Pharma Scient Appl NOVEL ANGIOTENSIN II RECEPTOR ANTAGONIST OXYPYRAZOLE DERIVATIVES; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
CA2058198A1 (en) * 1991-01-04 1992-07-05 Adalbert Wagner Azole derivatives, process for their preparation, and their use
IE920175A1 (en) * 1991-02-11 1992-08-12 Zeneca Ltd Nitrogen heterocycles
US5162340A (en) * 1991-05-10 1992-11-10 Merck & Co., Inc. Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
TW300219B (en) * 1991-09-14 1997-03-11 Hoechst Ag
US5130439A (en) * 1991-11-18 1992-07-14 Lo Young S Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
EP0550313A1 (en) * 1991-12-30 1993-07-07 Synthelabo 2-(Tetranol-5-yl)-(1,1'-biphenyl)derivatives, their preparation and use as intermediates

Also Published As

Publication number Publication date
FI940032L (en) 1994-07-07
CA2112795A1 (en) 1994-07-07
AU677247B2 (en) 1997-04-17
ATE183732T1 (en) 1999-09-15
BR9400018A (en) 1994-07-26
AU5302994A (en) 1994-07-14
FI940032A0 (en) 1994-01-04
JP3586288B2 (en) 2004-11-10
GR3031852T3 (en) 2000-02-29
NZ272704A (en) 1997-02-24
US5618975A (en) 1997-04-08
IL108262A0 (en) 1994-04-12
PL301778A1 (en) 1994-07-11
NZ250577A (en) 1997-02-24
EP0606065A1 (en) 1994-07-13
NO940023L (en) 1994-07-07
TW348175B (en) 1998-12-21
CN1096511A (en) 1994-12-21
KR940018349A (en) 1994-08-16
EP0606065B1 (en) 1999-08-25
HU9400018D0 (en) 1994-05-30
US5633400A (en) 1997-05-27
CZ1494A3 (en) 1994-08-17
FI940032A7 (en) 1994-07-07
DE59408646D1 (en) 1999-09-30
HRP940001A2 (en) 1996-06-30
ES2136669T3 (en) 1999-12-01
NO301878B1 (en) 1997-12-22
JPH06234690A (en) 1994-08-23
NO940023D0 (en) 1994-01-04
DK0606065T3 (en) 2000-03-13
HUT67406A (en) 1995-04-28
ZA9418B (en) 1994-08-18
SI9400003A (en) 1994-09-30

Similar Documents

Publication Publication Date Title
EP3812366B1 (en) A preparation method for m-diamide compounds
HU207841B (en) Process for producing biphenyl-carbonitrils
EP0026928A1 (en) 3,4-Diarylisoxazol-5-acetic acid compounds, process for preparing the same, and pharmaceuticals containing the same
BR112018011518B1 (en) METHOD OF PRODUCTION OF AROMATIC STARCH DERIVATIVE
CZ1494A3 (en) Process for preparing diphenyl derivatives, aromatic compound and its use
EP2799425A1 (en) Preparation process of an agonist of the thrombopoietin receptor
US4683234A (en) 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
CA2607934C (en) Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
JPH013173A (en) Method for producing oxophthalazinyl acetic acids having a heterocyclic side chain such as benzothiazole
JP7426481B2 (en) 3-N-cyclopropylmethyl-2-fluorobenzamide compounds, and their preparation and use
EP1858858B1 (en) Method for producing alkyl anilides
EP1773783B1 (en) Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
TW200538116A (en) Process for the preparation of substituted triazole compounds
US4902698A (en) Benzenesulphonamidopyridyl compounds which are useful as thromboxane A.sub.2
US3957785A (en) Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
CA1105933A (en) O-propyloximes
JPH029854A (en) Production of 3-amino-acrylonitrile
JPH01125345A (en) Production of pronenic acid derivative
JPS62175460A (en) Heteroaromatic acetylene useful as antihypertensive
CN101410386B (en) 2-alkenyl-3-aminothiophene derivative and its preparation method
CN106220554B (en) A kind of preparation method of arylpyridine and derivative thereof
US4085102A (en) 2-Amino-8-arylideno-3,4,5,6,7,8-hexahydro-4-arlypyrido[4,3-d]pyrimidines
HU199420B (en) Process for producing 5-halogen-6-aminonicotinic acid halides
JPS63239273A (en) Phenylimidazole derivative
CA1100504A (en) S-triazolo [1,5-a] pyridine derivatives